Vaccines

17 Apr 2017 ACARIZAX® approved in Europe for use in adolescent patients with house dust mite-induced allergic rhinitis
11 Apr 2017 Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial
11 Apr 2017 Zika virus: Themis Bioscience initiates worldwide first study with live attenuated recombinant vaccine
06 Apr 2017 Agenus Commences Phase 1 Trial with Neoantigen Cancer Vaccine AutoSynVax
05 Apr 2017 Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate
04 Apr 2017 Galena Biopharma Presents Positive Interim Safety Data on the NeuVax™ (nelipepimut-S) Clinical Trial in Combination with Trastuzumab in High-Risk HER2 3+ Patients at the AACR Annual Meeting 2017
03 Apr 2017 AXON's Tau Vaccine Offers Potential for Treating Frontotemporal Dementia Patients
30 Mar 2017 Inovio and Collaborators Receive NIH Grant to Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability to Induce Remission of HIV Infection and End Lifetime of Drug Therapy
29 Mar 2017 Immunovaccine Announces Positive Interim Clinical Data from Ovarian Cancer Study of DPX-Survivac in Combination with Epacadostat
28 Mar 2017 CureLab Oncology, Inc. Publishes Results of Phase I/IIa Clinical Trials of Its Anti-Cancer DNA Vaccine, Elenagen
24 Mar 2017 Pfizer Receives Positive CHMP Opinion for TRUMENBA® for Prevention of Meningococcal Group B Disease
24 Mar 2017 EU-funded consortium led by Immatics and BioNTech announces completion of regular study treatment in the GAPVAC-101 trial
22 Mar 2017 Heat Biologics Reports Positive Interim Phase 2 Lung Cancer Results in Patients Treated with HS-110 in Combination with a Checkpoint Inhibitor
20 Mar 2017 GeoVax Reports Promising Results for Zika Vaccine
15 Mar 2017 GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older
15 Mar 2017 BriaCell Receives FDA Clearance to Initiate Phase I/IIa Clinical Trial of BriaVax(TM) in Patients with Advanced Breast Cancer
14 Mar 2017 First Patient Dosed in Phase 2 Trial Evaluating Transgene’s TG4010 in Combination With Opdivo® (Nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
13 Mar 2017 Bavarian Nordic Announces Collaboration to Evaluate CV301 and Tecentriq in Bladder Cancer
09 Mar 2017 CyTuVax starts its Phase 2 BE RESPONDER! study
07 Mar 2017 Aimmune Therapeutics Presents Clinical Data on Phase 3 Screening and Phase 2 Adherence for AR101 for Peanut Allergy at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
02 Mar 2017 FDA approves Odactra for house dust mite allergies
28 Feb 2017 Astellas and Affinivax Announce Worldwide Partnership for MAPS Vaccine targeting Pneumococcal Disease
28 Feb 2017 Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy
27 Feb 2017 In First Phase 3 Trial, Merck’s Investigational Inactivated Varicella Zoster Virus Vaccine (V212) Reduced the Incidence of Confirmed Herpes Zoster Cases by an Estimated 64 Percent in Immunocompromised Subjects
24 Feb 2017 Oxford BioMedica Notes Encouraging Results of the Investigator Led Phase I/II clinical trial of MVA-5T4 Immunotherapy (TroVax®) and Low Dose Cyclophosphamide in Patients with Advanced Colorectal Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top